SYS-CON MEDIA Authors: Michael Bushong, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Precision Medicine, Big Data, Innovative Financing and Emerging Markets Are Focus of MIT Sloan BioInnovations Conference

Innovations in genomics technology have made the genetic information of individuals very accessible. This information, in turn, is being used in a growing array of diagnostic and treatment-tuning capacities.

On Friday, February 28, the MIT Sloan BioInnovations Conference will bring together industry, academic and policy leaders to address trends and new approaches to precision medicine along with the impact of big data on healthcare, innovative financing, and new opportunities in emerging markets. The conference will be held at the Boston Marriott Cambridge hotel in Kendall Square.

Slated keynote speakers are:

  • Dr. Margaret Hamburg, Commissioner, Food and Drug Administration
  • Dr. George Church, Wyss Institute of Synthetic Biology & Director of Personal Genome Project
  • Alex Azar, President, Lilly USA, LLC at Eli Lilly and Company
  • Kieran Murphy, President and CEO, GE Healthcare Life Sciences

Four panels will focus on:

Innovation Trends in Upstream R&D and Phase I Pipeline Development
A look at pre-competitive consortia of pharma companies, big-data-related methods of generating or capturing chemical and biological diversity, and novel therapeutic modalities such as RNA interference, gene therapy, cell therapy and viral therapy.

Big Data in Healthcare: Where Does That Lead Us?
A look at the wealth of opportunities and challenges brought on by big data, and how players in the healthcare industry are seeking to capitalize on this information to help drive more innovation to improve healthcare outcomes.

Seizing Uncaptured Opportunities in Emerging Markets
Common challenges around regulation, distribution, access, and affordability across diverse emerging markets, as well as innovative approaches in addressing these challenges will be explored.

Transforming Healthcare Entrepreneurship with Innovative Financing
The transformation of the US healthcare system has created a paradigm shift in how start-ups are seeded, grown, and assessed. This panel will encourage discussion on innovative approaches to grow and finance healthcare ventures.

For more information and to register, please visit: http://web.mit.edu/sloanhcc/bioinnovations/2014/.

About the MIT Sloan BioInnovations Conference
The MIT Sloan BioInnovations conference has established itself as an important forum for leaders in industry, academia, and policy to discuss current issues and future innovations in the dynamic area of healthcare, from healthcare in emerging markets to new drug technologies. Participants will hear from industry leaders in keynote addresses and panel discussions, will view new technological and business innovations from the many biomedical institutes and startups around Boston through poster presentations, and will have the opportunity to network with professionals and students from a variety of disciplines.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.